Information Provided By:
Fly News Breaks for December 11, 2018
AZN
Dec 11, 2018 | 07:52 EDT
Jefferies analyst Peter Welford assumed coverage of AstraZeneca with a Hold rating and $42 price target. The analyst is positive on the European large-cap Pharma space "as it enters a period of sustained earnings momentum."